178 related articles for article (PubMed ID: 8635060)
1. Familial cutaneous malignant melanoma and tumors of the nervous system. A hereditary cancer syndrome.
Azizi E; Friedman J; Pavlotsky F; Iscovich J; Bornstein A; Shafir R; Trau H; Brenner H; Nass D
Cancer; 1995 Nov; 76(9):1571-8. PubMed ID: 8635060
[TBL] [Abstract][Full Text] [Related]
2. A familial syndromic association between cutaneous malignant melanoma and neural system tumours.
Scope A; Friedman E; Azizi E
Br J Dermatol; 2004 Dec; 151(6):1278-9; author reply 1279. PubMed ID: 15606533
[No Abstract] [Full Text] [Related]
3. The familial occurrence of cutaneous melanoma, intraocular melanoma, and the dysplastic nevus syndrome.
Greene MH; Sanders RJ; Chu FC; Clark WH; Elder DE; Cogan DG
Am J Ophthalmol; 1983 Aug; 96(2):238-45. PubMed ID: 6881247
[TBL] [Abstract][Full Text] [Related]
4. Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors.
Bahuau M; Vidaud D; Jenkins RB; Bièche I; Kimmel DW; Assouline B; Smith JS; Alderete B; Cayuela JM; Harpey JP; Caille B; Vidaud M
Cancer Res; 1998 Jun; 58(11):2298-303. PubMed ID: 9622062
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: the familial atypical mole melanoma-pancreatic carcinoma syndrome.
Lynch HT; Brand RE; Hogg D; Deters CA; Fusaro RM; Lynch JF; Liu L; Knezetic J; Lassam NJ; Goggins M; Kern S
Cancer; 2002 Jan; 94(1):84-96. PubMed ID: 11815963
[TBL] [Abstract][Full Text] [Related]
6. Familial aggregation of malignant melanoma/dysplastic naevi and tumours of the nervous system: an original syndrome of tumour proneness.
Bahuau M; Vidaud D; Kujas M; Palangié A; Assouline B; Chaignaud-Lebreton M; Prieur M; Vidaud M; Harpey JP; Lafourcade J; Caille B
Ann Genet; 1997; 40(2):78-91. PubMed ID: 9259954
[TBL] [Abstract][Full Text] [Related]
7. Genetic study of familial uveal melanoma: association of uveal and cutaneous melanoma with cutaneous and ocular nevi.
Smith JH; Padnick-Silver L; Newlin A; Rhodes K; Rubinstein WS
Ophthalmology; 2007 Apr; 114(4):774-9. PubMed ID: 17207529
[TBL] [Abstract][Full Text] [Related]
8. Retinoblastoma, melanoma and the atypical mole syndrome.
Bataille V; Hiles R; Bishop JA
Br J Dermatol; 1995 Jan; 132(1):134-8. PubMed ID: 7756125
[TBL] [Abstract][Full Text] [Related]
9. High risk of malignant melanoma in melanoma-prone families with dysplastic nevi.
Greene MH; Clark WH; Tucker MA; Kraemer KH; Elder DE; Fraser MC
Ann Intern Med; 1985 Apr; 102(4):458-65. PubMed ID: 3977193
[TBL] [Abstract][Full Text] [Related]
10. Precursor lesions in familial melanoma.
Greene MH; Reimer RR; Clark WH; Mastrangelo MJ
Semin Oncol; 1978 Mar; 5(1):85-7. PubMed ID: 635599
[TBL] [Abstract][Full Text] [Related]
11. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.
Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG
Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773
[TBL] [Abstract][Full Text] [Related]
12. Acquired melanocytic nevi in childhood and familial melanoma.
Vredenborg A; Böhringer S; Boonk SE; Gruis NA; Out-Luijting C; Kukutsch NA; Bergman W
JAMA Dermatol; 2014 Jan; 150(1):35-40. PubMed ID: 24196164
[TBL] [Abstract][Full Text] [Related]
13. The miRNA machinery in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases and benign melanocytic nevi.
Sand M; Skrygan M; Georgas D; Sand D; Gambichler T; Altmeyer P; Bechara FG
Cell Tissue Res; 2012 Oct; 350(1):119-26. PubMed ID: 22706980
[TBL] [Abstract][Full Text] [Related]
14. [Family studies on the incidence of multiple pigmented naevi, familial skin melanoma and other malignant tumors].
Szekeres L; Korom I
Orv Hetil; 1991 Sep; 132(39):2153-6. PubMed ID: 1923488
[TBL] [Abstract][Full Text] [Related]
15. [Incidence of ocular pigment changes in patients with cutaneous melanoma].
Stosiek N; Heese A; Schell H; Hornstein OP
Hautarzt; 1993 May; 44(5):296-9. PubMed ID: 8320116
[TBL] [Abstract][Full Text] [Related]
16. Hereditary melanoma: Update on syndromes and management: Genetics of familial atypical multiple mole melanoma syndrome.
Soura E; Eliades PJ; Shannon K; Stratigos AJ; Tsao H
J Am Acad Dermatol; 2016 Mar; 74(3):395-407; quiz 408-10. PubMed ID: 26892650
[TBL] [Abstract][Full Text] [Related]
17. Histomorphologic spectrum of BAP1 negative melanocytic neoplasms in a family with BAP1-associated cancer susceptibility syndrome.
Marušić Z; Buljan M; Busam KJ
J Cutan Pathol; 2015 Jun; 42(6):406-12. PubMed ID: 25902915
[TBL] [Abstract][Full Text] [Related]
18. Genetics of familial and sporadic melanoma.
Bataille V
Clin Exp Dermatol; 2000 Sep; 25(6):464-70. PubMed ID: 11044180
[TBL] [Abstract][Full Text] [Related]
19. Origin of familial malignant melanomas from heritable melanocytic lesions. 'The B-K mole syndrome'.
Clark WH; Reimer RR; Greene M; Ainsworth AM; Mastrangelo MJ
Arch Dermatol; 1978 May; 114(5):732-8. PubMed ID: 646394
[TBL] [Abstract][Full Text] [Related]
20. The cutaneous evolution of nevi in a patient with familial, atypical, multiple-mole melanoma syndrome.
Lynch HT; Fusaro RM; Treger CL; Pester J; Lynch JF
Pediatr Dermatol; 1985 Jul; 2(4):289-93. PubMed ID: 4011507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
